• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面能变化及其与沙美特罗替卡松干粉在高相对湿度下储存后分散性的关系。

Surface energy changes and their relationship with the dispersibility of salmeterol xinafoate powders for inhalation after storage at high RH.

机构信息

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Victoria 3052, Australia.

出版信息

Eur J Pharm Sci. 2009 Nov 5;38(4):347-54. doi: 10.1016/j.ejps.2009.08.007. Epub 2009 Sep 2.

DOI:10.1016/j.ejps.2009.08.007
PMID:19732829
Abstract

This study investigated the relationship between surface energy of micronized lactose, coarse lactose and salmeterol xinafoate and dispersibility from a mixture after storage at 75% RH. Surface energies, dispersibility, morphology, and the presence of amorphous domains were determined by inverse gas chromatography, twin stage impinger, scanning electron microscope and dynamic vapour sorption, respectively. The fine particle fraction of mixture decreased significantly in 4 weeks (P<0.05), reaching a static level in 3 months. Amorphous content was not detected in the micronized lactose, coarse lactose and salmeterol xinafoate. After conditioning stored samples at 75% RH for 2h, dispersive surface energy of both micronized and coarse lactose significantly decreased (P<0.05), while the polar surface energy of all significantly increased (P<0.05) resulting in significant increase in total surface energy after storage. After conditioning stored samples at 0% RH for 2h, no significant difference was observed in any surface energy parameter. This study concluded that the total surface energy increased during storage at high RH due to the adhered surface moisture. The mechanism of decreased dispersibility was related to increased capillary/solid bridging interactions and to possible increased interaction of contiguous particles due to increased polar surface energy.

摘要

本研究考察了在 75%相对湿度下储存后,微粉化乳糖、粗乳糖和沙美特罗昔萘酸盐的表面能与混合物的分散性之间的关系。通过反气相色谱、双级撞击器、扫描电子显微镜和动态蒸汽吸附分别测定了表面能、分散性、形态和无定形区域的存在。在 4 周内(P<0.05),混合物的细颗粒分数显著降低,3 个月后达到静态水平。在微粉化乳糖、粗乳糖和沙美特罗昔萘酸盐中均未检测到无定形含量。在 75%RH 下储存的样品经过 2 小时调节后,微粉化乳糖和粗乳糖的分散表面能显著降低(P<0.05),而所有样品的极性表面能均显著增加(P<0.05),导致储存后总表面能显著增加。在 0%RH 下储存的样品经过 2 小时调节后,任何表面能参数均无显著差异。本研究得出结论,由于附着的表面水分,高 RH 储存期间总表面能增加。分散性降低的机制与毛细管/固体桥接相互作用的增加以及由于极性表面能的增加而可能导致相邻颗粒相互作用的增加有关。

相似文献

1
Surface energy changes and their relationship with the dispersibility of salmeterol xinafoate powders for inhalation after storage at high RH.表面能变化及其与沙美特罗替卡松干粉在高相对湿度下储存后分散性的关系。
Eur J Pharm Sci. 2009 Nov 5;38(4):347-54. doi: 10.1016/j.ejps.2009.08.007. Epub 2009 Sep 2.
2
Agglomerate properties and dispersibility changes of salmeterol xinafoate from powders for inhalation after storage at high relative humidity.高相对湿度储存后,吸入用粉雾剂中昔萘酸沙美特罗的聚集特性及分散性变化
Eur J Pharm Sci. 2009 Jun 28;37(3-4):442-50. doi: 10.1016/j.ejps.2009.03.016. Epub 2009 Apr 8.
3
Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation.储存相对湿度对吸入用昔萘酸沙美特罗粉分散性的影响。
J Pharm Sci. 2009 Mar;98(3):1015-27. doi: 10.1002/jps.21500.
4
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
5
Surface modification of lactose inhalation blends by moisture.水分对乳糖吸入混合物的表面改性。
Int J Pharm. 2010 May 31;391(1-2):29-37. doi: 10.1016/j.ijpharm.2010.02.011. Epub 2010 Feb 13.
6
Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation.添加的细乳糖的多分散性对昔萘酸沙美特罗从吸入用混合物中的分散度的影响。
Eur J Pharm Sci. 2009 Feb 15;36(2-3):265-74. doi: 10.1016/j.ejps.2008.10.001. Epub 2008 Oct 22.
7
Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.昔萘酸沙美特罗颗粒在吸入用糖基混合物中的黏附与再分布。
Int J Pharm. 2007 Jun 7;337(1-2):229-38. doi: 10.1016/j.ijpharm.2007.01.007. Epub 2007 Jan 14.
8
Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.储存湿度对表面覆盖乳糖载体的硫酸沙丁胺醇干粉体外吸入特性的影响
Chem Pharm Bull (Tokyo). 2004 Apr;52(4):444-6. doi: 10.1248/cpb.52.444.
9
Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures.载体大小对昔萘酸沙美特罗从交互式混合物中分散的影响。
J Pharm Sci. 2004 Apr;93(4):1030-8. doi: 10.1002/jps.10583.
10
Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography.通过使用反相气相色谱法的颗粒间相互作用分析预测干粉吸入制剂的气溶胶性能。
J Pharm Sci. 2006 Jan;95(1):228-33. doi: 10.1002/jps.20519.

引用本文的文献

1
Using Dry Dispersion Laser Diffraction to Assess Dispersibility in Spheronized Agglomerate Formulations.采用干法分散激光衍射评估球形团聚体配方中的分散性。
AAPS PharmSciTech. 2024 Feb 23;25(3):45. doi: 10.1208/s12249-024-02743-8.
2
Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.多粘菌素共喷雾干燥提高吸入性妥布霉素粉末制剂的气溶胶化稳定性。
Pharm Res. 2022 Nov;39(11):2781-2799. doi: 10.1007/s11095-022-03344-5. Epub 2022 Aug 2.
3
Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices.
COVID-19 的吸入疗法:药物、制剂和装置的考虑因素。
Int J Pharm. 2022 Aug 25;624:122042. doi: 10.1016/j.ijpharm.2022.122042. Epub 2022 Jul 20.
4
Multifunctional Role of Silica in Pharmaceutical Formulations.二氧化硅在药物制剂中的多功能作用。
AAPS PharmSciTech. 2022 Mar 16;23(4):90. doi: 10.1208/s12249-022-02237-5.
5
Co-Amorphization of Kanamycin with Amino Acids Improves Aerosolization.卡那霉素与氨基酸的共无定形化改善了雾化效果。
Pharmaceutics. 2020 Jul 30;12(8):715. doi: 10.3390/pharmaceutics12080715.
6
Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.常用干粉吸入器抗湿性差异的体外研究。
NPJ Prim Care Respir Med. 2016 Nov 17;26:16053. doi: 10.1038/npjpcrm.2016.53.
7
Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.研制更理想的干粉吸入剂配方:大喷雾干燥甘露醇微球优于小微球。
Pharm Res. 2014 Jan;31(1):60-76. doi: 10.1007/s11095-013-1132-2. Epub 2013 Aug 6.
8
Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.使用干法分散激光衍射快速表征可吸入粉末的固有分散性。
Int J Pharm. 2013 Apr 15;447(1-2):124-31. doi: 10.1016/j.ijpharm.2013.02.034. Epub 2013 Feb 19.